Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
- PMID: 1379906
- DOI: 10.2165/00003495-199244010-00001
Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
Similar articles
-
[Chemotherapy of malignant lymphomas].Radiol Med. 1976 Jul-Aug;62(7-8):553-7. Radiol Med. 1976. PMID: 95671 Review. Italian.
-
Chemotherapy of Hodgkin's disease.Nouv Rev Fr Hematol (1978). 1990;32(2):169-73. Nouv Rev Fr Hematol (1978). 1990. PMID: 1696000 Review.
-
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.J Clin Oncol. 1994 Jul;12(7):1366-74. doi: 10.1200/JCO.1994.12.7.1366. J Clin Oncol. 1994. PMID: 7517442 Clinical Trial.
-
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.J Clin Oncol. 2003 May 1;21(9):1734-9. doi: 10.1200/JCO.2003.06.028. J Clin Oncol. 2003. PMID: 12721249 Clinical Trial.
-
[The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].Nouv Rev Fr Hematol (1978). 1988;30(1-2):131-4. Nouv Rev Fr Hematol (1978). 1988. PMID: 2455276 Review. French.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical